Developer docs
API playgroundTry for free, no card

Search company profiles

BEYEONICS

Full company profile

uuid002vgva

Namestring
BEYEONICS
Legal namestring
Beyeonics Vision Ltd.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Beyeonics Vision Ltd. is an Israel-based medical device company that develops and commercializes the Beyeonics One, the first ophthalmic exoscope combining a digital stereoscopic camera head (>8K resolution) with an augmented-reality surgical headset. The company's core technology is adapted from Elbit Systems' aviation headset and display IP originally developed for fighter jet cockpits and re-engineered for ophthalmic surgery. Key product features include infrared (IR) illumination ("Invisible Light") for visualization through hemorrhage, cloudy cornea, and dense lenses; zero-latency real-time video processing; head-gesture controls for focus, zoom, pan and illumination; automation such as auto-focus, auto-centering and automatic anterior/posterior mode switching; and optional Intraoperative OCT. The system supports cataract, retina, glaucoma and cornea procedures and includes a 24-inch touchscreen, motorized positioning arm, and dual-headset capability for teaching.

The business model is built on capital-equipment sales of the Beyeonics One console, camera head, AR headset and accessories to ambulatory surgery centers, eye institutes and hospitals, alongside service and remote-support contracts enabled by the platform's connectivity. Pricing is quote-based and not publicly disclosed. The go-to-market is enterprise field sales combined with high-visibility presence at major ophthalmology conferences (ASCRS, AAO, EURETINA, Retina Fellows Forum) and key opinion leader engagement; distribution is reinforced by a strategic co-development partnership with ophthalmic OEM BVI. Beyeonics sells into North America (via Beyeonics USA, Inc. in Wilmington, DE) and EMEA (with CE Mark obtained in September 2022). The company operates as a spin-off of Elbit Systems with $36 million of disclosed funding from the parent (October 2021), a leadership team built around a CEO appointed in March 2024 and a Chairman appointed in January 2025, and is in early commercial ramp with its first disclosed US installation in June 2024.

Short descriptiontext

Beyeonics Vision Ltd. is an Israel-based medical device company that sells the Beyeonics One, the first digital ophthalmic exoscope with an augmented-reality surgical headset, to eye surgeons, ambulatory surgery centers, and eye institutes for cataract, retina, glaucoma, and cornea procedures.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersTirat Carmel, Israel
HQ citystring
Tirat Carmel
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic surgical visualization, augmented reality surgery, digital surgical microscope, ophthalmic medical devices, surgical imaging systems
Industry3 codes
1Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
CodeHLAHADADPrimaryYes
2Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
CodeHLAHADAHPrimaryNo
3Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
CodeHLAHAJABPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Ophthalmic Surgical Visualization Systems
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of Beyeonics One digital exoscope system and components including the AR surgical headset, console, camera head unit, and motorized arm. One-time capital equipment purchase model typical for surgical visualization systems in healthcare facilities.

beyeonics-vision.com
2Service and Support Contracts
TypeManaged Services
Description

Remote connectivity for service and training enhancements suggests ongoing support and maintenance contracts alongside hardware sales.

beyeonics-vision.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Beyeonics One®
Description

The first digital microscope with augmented reality surgical headset for ophthalmic surgery, featuring invisible light technology powered by infrared illumination.

beyeonics-vision.com
+1 more record
Core offering1 text field

BEYEONICS manufactures and sells the Beyeonics One ophthalmic exoscope, a high-definition fully digital imaging platform for ophthalmic surgeons that combines a stereoscopic camera head unit (>8K resolution), a console for real-time video processing, a motorized positioning arm, and a lightweight augmented reality surgical headset with head-gesture controls. The system also features proprietary infrared (IR) "Invisible Light" illumination for visualization through opaque ocular media and supports Intraoperative OCT for advanced intraoperative imaging.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Zero perceived image latency enabling continuous surgical workflow
+3 more records
Product overview1 text field

Beyeonics offers a unified digital surgical platform called Beyeonics One™ — the first Ophthalmic Exoscope combining digital imaging with augmented reality. The core system consists of the main console (real-time video processing), AR surgical headset (for immersive 3D visualization), and stereoscopic camera head unit (>8K resolution). Key technology features include Invisible Light (infrared illumination) for enhanced visualization through challenging anatomy, and Intraoperative OCT for advanced intraoperative imaging. The platform supports anterior and posterior ophthalmic procedures including cataract, retina, glaucoma, and cornea surgeries. An open platform architecture enables future integration with EMR/PACS systems.

Product and service1 record
1Beyeonics One™ Ophthalmic Exoscope
CategoryOphthalmic Surgical Visualization Systems
Description

The first digital microscope with augmented reality surgical headset for ophthalmic surgery. A high-definition fully digital imaging platform that enables surgeons to see a magnified, three-dimensional image of the surgical field with on-demand preoperative information displayed through an immersive AR headset. Sold as a capital system to ophthalmic surgeons, eye clinics, ambulatory surgery centers, and eye institutes for use in cataract, retina, glaucoma, and cornea surgery.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

BVI announced collaboration with Beyeonics Vision. BVI is a significant player in the ophthalmology space. The partnership enables integration and co-development of surgical visualization solutions for ophthalmic procedures.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Alcon's NGENUITY 3D Visualization System is the closest direct competitor — a digital 3D surgical visualization platform for ophthalmology. Both target vitreoretinal and cataract surgeons with digital/3D alternatives to traditional optical microscopes.

TypeRegional player
Description

Optos (now part of Nikon) provides ultra-widefield retinal imaging used in ophthalmology workflows. Adjacent rather than direct overlap, but competes for retina practice capital and is a meaningful player in ophthalmic imaging innovation.

TypeEmerging player
Description

Heidelberg Engineering's SPECTRALIS platform and intraoperative OCT modules target retinal imaging within ophthalmology, including surgical applications. Partial overlap with Beyeonics' Intraoperative OCT capability and retina-surgery positioning.

TypeEmerging player
Description

TrueVision pioneered 3D heads-up ophthalmic visualization before being acquired by Alcon and folded into NGENUITY. Historically a direct digital-viz competitor to Beyeonics in retina and anterior segment surgery.

TypeBroad incumbent
Description

NIDEK manufactures ophthalmic surgical equipment and visualization systems globally and is an established player in cataract and retina surgical suites. Overlaps with Beyeonics in serving ophthalmic surgeons with OR visualization and imaging technology.

TypeBroad incumbent
Description

Topcon provides ophthalmic diagnostic and surgical imaging systems (including 3D OCT-1 and surgical visualization) and competes for the same eye-care clinical budget pool. Broad incumbent with deep optometry/ophthalmology distribution channels.

TypeBroad incumbent
Description

Zeiss dominates ophthalmic surgical microscopy (OPMI Lumera, Artevo 800) and is the entrenched incumbent in cataract and retina visualization. Directly comparable to Beyeonics in end-user specialty, with overlapping OR visualization capabilities though delivered via optical rather than digital AR headsets.

TypeEmerging player
Description

IRIDEX develops ophthalmic laser and visualization systems used in retinal and glaucoma surgery. Adjacent competitor for ophthalmic OR capital budgets and a comparable early-to-mid commercial stage medical device company.

TypeBroad incumbent
Description

Leica's surgical microscopes (M844, PROvido) compete for the same ophthalmology and microsurgery OR visualization budgets as Beyeonics. A broad incumbent with established service networks and integration into hospital procurement frameworks.

TypeEmerging player
Description

Olympus's VISERA 4K UHD and Sony-Olympus surgical visualization collaborations address digital OR imaging across specialties. Comparable as digital surgical visualization competitors, though not ophthalmology-specialized like Beyeonics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BEYEONICS

Ophthalmic Surgical Visualization Systemsbeyeonics-vision.com

Beyeonics Vision Ltd. is an Israel-based medical device company that sells the Beyeonics One, the first digital ophthalmic exoscope with an augmented-reality surgical headset, to eye surgeons, ambulatory surgery centers, and eye institutes for cataract, retina, glaucoma, and cornea procedures.

What BEYEONICS does

Beyeonics Vision Ltd. is an Israel-based medical device company that develops and commercializes the Beyeonics One, the first ophthalmic exoscope combining a digital stereoscopic camera head (>8K resolution) with an augmented-reality surgical headset. The company's core technology is adapted from Elbit Systems' aviation headset and display IP originally developed for fighter jet cockpits and re-engineered for ophthalmic surgery. Key product features include infrared (IR) illumination ("Invisible Light") for visualization through hemorrhage, cloudy cornea, and dense lenses; zero-latency real-time video processing; head-gesture controls for focus, zoom, pan and illumination; automation such as auto-focus, auto-centering and automatic anterior/posterior mode switching; and optional Intraoperative OCT. The system supports cataract, retina, glaucoma and cornea procedures and includes a 24-inch touchscreen, motorized positioning arm, and dual-headset capability for teaching.

The business model is built on capital-equipment sales of the Beyeonics One console, camera head, AR headset and accessories to ambulatory surgery centers, eye institutes and hospitals, alongside service and remote-support contracts enabled by the platform's connectivity. Pricing is quote-based and not publicly disclosed. The go-to-market is enterprise field sales combined with high-visibility presence at major ophthalmology conferences (ASCRS, AAO, EURETINA, Retina Fellows Forum) and key opinion leader engagement; distribution is reinforced by a strategic co-development partnership with ophthalmic OEM BVI. Beyeonics sells into North America (via Beyeonics USA, Inc. in Wilmington, DE) and EMEA (with CE Mark obtained in September 2022). The company operates as a spin-off of Elbit Systems with $36 million of disclosed funding from the parent (October 2021), a leadership team built around a CEO appointed in March 2024 and a Chairman appointed in January 2025, and is in early commercial ramp with its first disclosed US installation in June 2024.

BEYEONICS firmographics

Firmographics
Name
BEYEONICS
Legal name
Beyeonics Vision Ltd.
Website
https://beyeonics-vision.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Beyeonics Vision Ltd. is an Israel-based medical device company that sells the Beyeonics One, the first digital ophthalmic exoscope with an augmented-reality surgical headset, to eye surgeons, ambulatory surgery centers, and eye institutes for cataract, retina, glaucoma, and cornea procedures.
Ownership category
akta.pro rank

BEYEONICS industry classification

Industry
Product category
Ophthalmic Surgical Visualization Systems
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD)
akta.pro secondary industries
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography) (HLAHAJAB)

Keywords

  • Ophthalmic surgical visualization
  • Augmented reality surgery
  • Digital surgical microscope
  • Ophthalmic medical devices
  • Surgical imaging systems

Where BEYEONICS is headquartered

Location

Headquarters

HQ city
Tirat Carmel
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

BEYEONICS business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Hardware Sales: Sale of Beyeonics One digital exoscope system and components including the AR surgical headset, console, camera head unit, and motorized arm. One-time capital equipment purchase model typical for surgical visualization systems in healthcare facilities.
  2. Service and Support Contracts: Remote connectivity for service and training enhancements suggests ongoing support and maintenance contracts alongside hardware sales.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

BEYEONICS product offering

Product offering

Core offering

BEYEONICS manufactures and sells the Beyeonics One ophthalmic exoscope, a high-definition fully digital imaging platform for ophthalmic surgeons that combines a stereoscopic camera head unit (>8K resolution), a console for real-time video processing, a motorized positioning arm, and a lightweight augmented reality surgical headset with head-gesture controls. The system also features proprietary infrared (IR) "Invisible Light" illumination for visualization through opaque ocular media and supports Intraoperative OCT for advanced intraoperative imaging.

Product overview

Beyeonics offers a unified digital surgical platform called Beyeonics One™ — the first Ophthalmic Exoscope combining digital imaging with augmented reality. The core system consists of the main console (real-time video processing), AR surgical headset (for immersive 3D visualization), and stereoscopic camera head unit (>8K resolution). Key technology features include Invisible Light (infrared illumination) for enhanced visualization through challenging anatomy, and Intraoperative OCT for advanced intraoperative imaging. The platform supports anterior and posterior ophthalmic procedures including cataract, retina, glaucoma, and cornea surgeries. An open platform architecture enables future integration with EMR/PACS systems.

Differentiator

Problem solved

Functional benefit

Brands

  • Beyeonics One®: The first digital microscope with augmented reality surgical headset for ophthalmic surgery, featuring invisible light technology powered by infrared illumination.
  • Unconstrained Performance™

Products and services

  • Beyeonics One™ Ophthalmic Exoscope The first digital microscope with augmented reality surgical headset for ophthalmic surgery. A high-definition fully digital imaging platform that enables surgeons to see a magnified, three-dimensional image of the surgical field with on-demand preoperative information displayed through an immersive AR headset. Sold as a capital system to ophthalmic surgeons, eye clinics, ambulatory surgery centers, and eye institutes for use in cataract, retina, glaucoma, and cornea surgery.

Quantifiable outcome

  • Zero perceived image latency enabling continuous surgical workflow
  • +3 more outcomes

Companies that use BEYEONICS

Customer profile

Named customers12 records

Segments2 records

Ideal customer profiles2 records

BEYEONICS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature8 records

BEYEONICS partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BVI (BVI)coreStrategic or Co-development PartnerBVI announced collaboration with Beyeonics Vision. BVI is a significant player in the ophthalmology space. The partnership enables integration and co-development of surgical visualization solutions for ophthalmic procedures.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

BEYEONICS competitors and assessment

Company assessment

Direct peers

  • Alcon: Alcon's NGENUITY 3D Visualization System is the closest direct competitor — a digital 3D surgical visualization platform for ophthalmology. Both target vitreoretinal and cataract surgeons with digital/3D alternatives to traditional optical microscopes.

Regional players

  • Optos (Nikon Healthcare): Optos (now part of Nikon) provides ultra-widefield retinal imaging used in ophthalmology workflows. Adjacent rather than direct overlap, but competes for retina practice capital and is a meaningful player in ophthalmic imaging innovation.

Emerging players

  • Heidelberg Engineering: Heidelberg Engineering's SPECTRALIS platform and intraoperative OCT modules target retinal imaging within ophthalmology, including surgical applications. Partial overlap with Beyeonics' Intraoperative OCT capability and retina-surgery positioning.
  • TrueVision Systems (Alcon): TrueVision pioneered 3D heads-up ophthalmic visualization before being acquired by Alcon and folded into NGENUITY. Historically a direct digital-viz competitor to Beyeonics in retina and anterior segment surgery.
  • IRIDEX: IRIDEX develops ophthalmic laser and visualization systems used in retinal and glaucoma surgery. Adjacent competitor for ophthalmic OR capital budgets and a comparable early-to-mid commercial stage medical device company.
  • Sony Olympus Medical Solutions: Olympus's VISERA 4K UHD and Sony-Olympus surgical visualization collaborations address digital OR imaging across specialties. Comparable as digital surgical visualization competitors, though not ophthalmology-specialized like Beyeonics.

Broad incumbents

  • NIDEK: NIDEK manufactures ophthalmic surgical equipment and visualization systems globally and is an established player in cataract and retina surgical suites. Overlaps with Beyeonics in serving ophthalmic surgeons with OR visualization and imaging technology.
  • Topcon Healthcare: Topcon provides ophthalmic diagnostic and surgical imaging systems (including 3D OCT-1 and surgical visualization) and competes for the same eye-care clinical budget pool. Broad incumbent with deep optometry/ophthalmology distribution channels.
  • Carl Zeiss Meditec: Zeiss dominates ophthalmic surgical microscopy (OPMI Lumera, Artevo 800) and is the entrenched incumbent in cataract and retina visualization. Directly comparable to Beyeonics in end-user specialty, with overlapping OR visualization capabilities though delivered via optical rather than digital AR headsets.
  • Leica Microsystems (Danaher): Leica's surgical microscopes (M844, PROvido) compete for the same ophthalmology and microsurgery OR visualization budgets as Beyeonics. A broad incumbent with established service networks and integration into hospital procurement frameworks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

BEYEONICS social profiles

Digital presence

BEYEONICS compliance and trust

Trust signal

Compliance1 record

BEYEONICS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BEYEONICS leadership team

Management profile

Number of profiles

Profiles13 records

BEYEONICS subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

BEYEONICS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BEYEONICS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BEYEONICS

What does BEYEONICS do?

BEYEONICS manufactures and sells the Beyeonics One ophthalmic exoscope, a high-definition fully digital imaging platform for ophthalmic surgeons that combines a stereoscopic camera head unit (>8K resolution), a console for real-time video processing, a motorized positioning arm, and a lightweight augmented reality surgical headset with head-gesture controls. The system also features proprietary infrared (IR) "Invisible Light" illumination for visualization through opaque ocular media and supports Intraoperative OCT for advanced intraoperative imaging.

Is BEYEONICS a public or private company?

BEYEONICS is a private company. It is classified as corporate owned and is currently operating.

When was BEYEONICS founded?

BEYEONICS was founded in 2018. It employs 51 to 100 people.

Where is BEYEONICS based?

BEYEONICS is headquartered in Tirat Carmel, Israel, in the Middle East region.

How does BEYEONICS make money?

Two revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are service and Support Contracts.

Who are BEYEONICS's main competitors?

Alcon is listed as a direct peer. Optos (Nikon Healthcare) is listed as a regional player. Emerging players are Heidelberg Engineering, TrueVision Systems (Alcon), IRIDEX and Sony Olympus Medical Solutions. Broad incumbents are NIDEK, Topcon Healthcare, Carl Zeiss Meditec and Leica Microsystems (Danaher).

Does BEYEONICS have an API?

No public API is recorded for BEYEONICS.

What industry is BEYEONICS in?

BEYEONICS's product category is Ophthalmic Surgical Visualization Systems. Its primary akta.pro industry code is HLAHADAD, Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing), with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Research NesterOphthalmic Viscosurgical Devices Market Size, Forecast Report 2035The global ophthalmic viscosurgical devices market was valued at USD 473.84 million in 2025 and is projected to reach USD 856.61 million by 2035, expanding at a compound annual growth rate of 6.1%. North America is expected to maintain its leading regional position with 39.3% revenue share by 2035, driven by advanced healthcare infrastructure and high surgical volumes, while Asia Pacific is anticipated to grow at the fastest pace due to rising healthcare spending and increasing cataract procedures. Key growth drivers include the aging global population, demand for minimally invasive procedures, and technological innovations such as Alcon's FDA-approved UNITY Cataract System and Beyeonics Vision's fully digital ophthalmic microscope.PR NewswireBeyeonics Vision Ltd. Appoints Michael Brownell as Chairman of the BoardBeyeonics Vision Ltd., an Israel-based ophthalmology visualization technology company, has appointed Michael Brownell as Chairman of its Board. Brownell brings over 35 years of technology experience including more than 20 years in ophthalmology, having previously served as CEO of Gobiquity, VP of R&D at Intralase (acquired by AMO), and most recently as Chairman and advisor at AcuSurgical. The company stated this appointment will support advancement of its proprietary IR imaging technology and accelerate commercial and business growth.PR NewswireBeyeonics Vision Appoints A. Burton Tripathi, PhD, as CEOBeyeonics Vision Ltd. has appointed A. Burton Tripathi, PhD, as its new Chief Executive Officer to lead the company's strategic direction and growth. Dr. Tripathi brings over two decades of medical device leadership experience, including recent roles at TrueVision Systems Inc., Alcon, and Intuitive Surgical.PR NewswireSurgical Reality Pioneer, Beyeonics, Unveils New Chairman of the BoardBeyeonics Surgical and Beyeonics Vision, Israeli MedTech companies specializing in digital surgical platforms for ophthalmology and neurosurgery, announced the appointment of Joseph C. Papa as Chairman of the Board of Beyeonics Surgical and Board Member of Beyeonics Vision. Papa previously served as Chairman and CEO of Bausch Health Companies Inc. and held leadership roles at Perrigo, Prometheus Biosciences, and SparingVision. The company stated that Papa's appointment reflects its commitment to advancing its technological roadmap and expanding its impact in the healthcare landscape.